← Eichor
Study identifier: NCT06994182 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study

Condition: Cancer Survivors  ·  Sponsor: Azienda USL Reggio Emilia - IRCCS

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work reintegration. In Italy there is lack of knowledge regarding this topic. Thus, further exploration of Italian employers' perspectives on the RTW of employees with cancer should be performed to comprehend their unknown experiences. The aim is to explore the perspectives of employers who dealt with the RTW process of employees who received a cancer diagnosis through a qualitative research design.

This description comes directly from the study's public registry record.

Talk to the study team

Sara Paltrinieri, PhD, OT  ·  0039 0522 522416  ·  sara.paltrinieri@ausl.re.it

Stefania Costi, PhD, PT  ·  0039 0522 522441  ·  stefania.costi@unimore.it

Always discuss trial participation with your own doctor first.

Locations (1)

Azienda USL IRCCS di Reggio EmiliaReggio Emilia, RE, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06994182